cbdMD, Inc. has entered into a definitive asset purchase agreement to acquire the operating assets and brands of Twinlab, including Twinlab, Reserveage, Metabolife and Alvita Tea. The transaction is being pursued through an assignment for the benefit of creditors, or ABC, an orderly creditor-resolution process, and remains subject to court approval and customary closing conditions. Based on unaudited financial information, the businesses generated approximately $30 million in combined trailing-12-month revenue through June 2026, about 40% above cbdMD's standalone revenue for the same period. cbdMD said the deal would reduce its concentration in hemp-derived products and expand its multi-brand consumer wellness platform, while noting that the combined revenue figure is illustrative and not a forecast of future results.